2,042 research outputs found
Death by Facial and Skull Injuries of a Motorcyclist Wearing a Full-Face Helmet: Case Report and Literature Review
We describe a case of death by facial and skull fractures with brain injuries of a motorcyclist wearing a full-face
helmet. A 40-year-old man driving a high-powered motorcycle crashed violently into the rear of a stopped car. The
main results from the autopsy revealed the deformation of the left orbito-zygomatic and fronto-temporoparietal
regions corresponding to bone fractures with laceration at the left temporal lobe. The CT scan of the helmet revealed
the detachment of the energy-absorbing liner. Moreover an impact speed of 93 Km/h resulted from the analysis of
accident dynamics. We analysed the literature regarding the effectiveness of full-face helmets in reducing the risk of
fatality and we sought the factors that may have deleted the protection offered. The lesions causing death were due
to high speed and probably the inadequacy of the helmet
Supply chain management as a competitive advantage in the Spanish grocery sector
Adversarial relationships have long dominated business relationships, but Supply Chain Management (SCM) entails a new perspective. SCM requires a movement away from arms-length relationships toward partnership style relations. SCM involves integration, co-ordination and collaboration across organisations and throughout the supply chain. It means that SCM requires internal (intraorganisational) and external (interorganisational) integration. This paper analyses the relationship between internal and external integration processes, their effect on firms’ performance and their contribution to the achievement of a competitive advantage. Performance improvements are analysed through costs, stock out and lead time reductions. And, the achievement of a better competitive position is measured by comparing the firm’s performance with its competitors’ performance. To analyse this, an empirical study has been conducted in the Spanish grocery sector.Supply chain management, logistics integration processes, Internal and externalintegration, competitive advantage, logistics performance
Logistics-production, logistics-marketing and external integration: Their impact on performance
Highly competitive environments are leading companies to implement Supply Chain Management (SCM) to improve performance and gain a competitive advantage. SCM involves integration, co-ordination and collaboration across organisations and throughout the supply chain. It means that SCM requires internal (intraorganisational) and external (interorganisational) integration. This paper examines the Logistics-Production and Logistics- Marketing interfaces and their relation with the external integration process. The study also investigates the causal impact of these internal and external relationships on the company’s logistical service performance. To analyse this, an empirical study was conducted in the Spanish Fast Moving Consumer Goods (FMCG) sector.Logistics integration processes, internal and external integration, logistics performance
Peculiar and Unusual Drowning in Waste Oil from Motor Vehicles: Case Report
Drowning is one of the most frequent causes of accidental or suicidal death, and more rarely it is associated with
a homicide. Cases of drowning in water or in the sea are common. The authors report an unusual and peculiar case
of drowning, that of a woman who accidentally fell inside a collection tank of waste oil of motor vehicles
In vitro genotoxic and epigenotoxic effects of occupational exposure to nanofibres
ABSTRACT - In recent years, human exposure to nanofibres (i.e., fibres with diameters < 100 nm) has
considerably increased due to their incorporation in a wide range of consumer products.
As such, there is a growing concern that the distinctive physicochemical characteristics
of nanofibres may lead to adverse human health effects, mainly by their inhalation in
occupational settings. Several toxicological studies have indicated that some nanofibres,
such as the MWCNT-7, display in vitro toxicity and induce pulmonary inflammation,
fibrosis, granulomas and carcinogenesis in vivo. Others, like cellulose nanofibrills (CNF),
seem biocompatible and promising for biomedical applications. Thus, the genotoxic
effects of nanofibres must be deeply studied to identify their possible hazard, and new
“omics” methodologies can uncover their underlying mechanisms of action. Moreover,
distinctive genomic or epigenomic expression profiles may be biomarkers of
occupational exposure to nanofibres. In this work, the two above-mentioned nanofibres
are analyzed in vitro, and the toxic effects of MWCNT-7 compared to those of crocidolite
asbestos. Cytotoxicity and genotoxicity were investigated through conventional assays,
and the differentially expressed microRNA (DE miRNA) in alveolar epithelial cells
exposed to MWCNT-7 or crocidolite identified by next-generation sequencing. The
overall results demonstrate that MWCNT-7 is cytotoxic, genotoxic and immunotoxic.
Notably, it induced nucleoplasmic bridges in alveolar cells, possibly due to its
resemblance with the microtubules and physical interference with the mitotic spindle.
Different viabilities and micronucleus frequencies were observed in alveolar cells when
using a conventional monoculture or a co-culture of these cells with macrophages, which
may be related to their epithelial-mesenchymal transition and consequent increase of
cell resistance to apoptosis. Regarding CNF, at low concentrations it stimulates cell
proliferation, whereas at higher ones it is moderately toxic. Although no immunotoxicity
and no significant DNA damage were detected, low CNF doses induced micronucleus.
Concerning the epigenotoxic study, several DE miRNA were identified in alveolar cells
exposed to MWCNT-7 or crocidolite, and a unique set was identified for each exposure.
Both materials caused common changes in pathways related to cell metabolism, cell
growth and death, cell-to-cell communication, protein processing, and signal
transduction. Other functional pathways were distinctively identified for each material that
sugest particular mechanisms of action. Since most are cancer related, a network of DE
miRNA and target cancer genes was constructed, highlighting the carcinogenic potential
of both materials.RESUMO - Nos últimos anos, a exposição humana a nanofibras (i.e., fibras com diâmetros <100
nm) tem vindo a aumentar, devido à sua incorporação em vários produtos para consumo
humano. Como tal, a preocupação de que as caracterĂsticas singulares das nanofibras
possam ter efeitos adversos na saĂşde humana tem-se intensificado, particularmente por
inalação em contexto ocupacional. Diversos estudos toxicológicos indicam que certas
nanofibras, como o MWCNT-7, têm toxicidade in vitro e induzem inflamação pulmonar,
fibrose, granulomas e carcinogénese in vivo. Outras, como a celulose nanofibrilar (CNF),
aparentam biocompatibilidade e são prometedoras para aplicações biomédicas. Desta
forma, Ă© essencial aprofundar o estudo sobre a sua genotoxicidade para conhecer a sua
perigosidade. Neste contexto, as metodologias “ómicas” permitem compreender os
mecanismos de ação das nanofibras e, além disso, os perfis genómicos ou
epigenómicos podem ser úteis como biomarcadores de exposição ocupacional. Neste
trabalho, as nanofibras acima citadas sĂŁo analisadas in vitro, sendo o MWCNT-7
comparado Ă crocidolite (amianto). A citotoxicidade e genotoxicidade sĂŁo analisadas
pelos ensaios convencionais, sendo ainda identificados quais os microRNA
diferencialmente expressos (miRNA DE) nas células alveolares expostas ao MWCNT-7
ou à crocidolite, por sequenciação de nova geração. Os resultados globais indicam que
o MWCNT-7 é citotóxico, genotóxico e imunotóxico. De realçar a indução de pontes
nucleoplásmicas nas células alveolares, provavelmente relacionadas com a
semelhança do MWCNT-7 aos microtúbulos e interferência com o fuso mitótico. A
diferente viabilidade e frequência de micronúcleos nas células alveolares em
monocultura ou co-cultura com macrófagos pode estar relacionada com a sua transição
epitelial-mesenquimal e aumento da resistĂŞncia Ă apoptose. Quanto Ă CNF, observouse
proliferação celular nas doses baixas e citotoxicidade moderada nas doses mais
elevadas. Embora nĂŁo se tenham detetado danos significativos no DNA ou
imunotoxicidade, foram induzidos micronĂşcleos nas doses baixas. No que respeita ao
estudo de epigenotoxicidade, foi identificado um conjunto Ăşnico de miRNA DE nas
células expostas ao MWCNT-7 ou à crocidolite. Ambos os materiais causaram as
mesmas alterações em vias de metabolismo celular, crescimento e morte celular,
comunicação cĂ©lula-a-cĂ©lula, processamento proteĂco e transdução de sinal. Outras
vias distintamente alteradas sugerem mecanismos de acção especĂficos. Uma vez que
a maioria está associada a cancro, foi construĂda uma rede entre miRNAs DE e genes
alvo associados a cancro que realça o potential carcinogénico de ambos os materiais
Evaluating the Maximization-Maximization approach to measure default probabilities on structural credit risk models
This thesis implements the Maximization-Maximization (MM) algorithm proposed by Forte and Lovreta (2012), where in the first step the expected assets rate of return and the asset volatility are estimated applying the Maximum Likelihood technique. As the firm’s assets value is not observable, the observed equity values are treated as transformed data in order to derive the log-likelihood function. In a second step, the default barrier is estimated according to the interests of shareholders, corresponding to the optimal level considered for the firm to default, and as the one that maximizes their participation. Using a sample of fifty-five companies and a time period for the estimation of one year, our results prove that estimating the expected rate of return is hard and does not provide statistically significant results, as it is dependent and highly correlated to the observed equity values. The results for the five-year default probabilities computed were most of them equal to zero or too high.Esta tese implementa o algoritmo Maximization-Maximization (MM) proposto por Forte e Lovreta (2012), em que no primeiro passo, o retorno esperado dos ativos e a volatilidade destes sĂŁo estimados aplicando a tĂ©cnica da Máxima Verosimilhança. Como o valor dos ativos da empresa nĂŁo Ă© observável, os valores do capital prĂłprio sĂŁo tratados como dados transformados de forma a derivar a função log-likelihood. Num segundo passo, a barreira de incumprimento Ă© estimada de acordo com os interesses dos acionistas, correspondendo ao nĂvel Ăłtimo considerado para a empresa entrar em incumprimento, bem como Ă quela que maximiza a participação destes. Usando uma amostra de cinquenta e cinco empresas e um perĂodo de tempo de um ano para a estimação, os nossos resultados mostram que estimar a taxa de retorno esperado dos ativos Ă© difĂcil e nĂŁo fornece resultados estatisticamente significativos, por ser dependente e fortemente correlacionado com os valores do capital prĂłprio. Os resultados das probabilidades de incumprimento a cinco anos calculadas foram na maioria igual a zero ou demasiado altas
Development of Models for On-line Diagnostic and Energy Assessment Analysis of PV Power Plants: The Study Case of 1 MW Sicilian PV Plant
Abstract For photovoltaic (PV) power plants, every kilowatt-hour is important, because only kilowatt-hours that are fed into the grid are remunerated. A plant's operator can only adopt prompt measures to eliminate operational faults when these are immediately signaled. In fact, just reading the feed-in meter each month is not sufficient to promptly recognize faults and to avoid the loss of yields. Many inverters record the most important operational data, automatically evaluate the data and, in case of a fault, send the operator notifications via email or text message. However, it only allows obvious faults to be recorded. On the other hand, continuous, absolute and comparative measurements are necessary to ensure the maximum efficiency and availability. Based on real time and historical data, a technical plant manager should inform the operators of any fault which occurs or even take independent measures to rectify it. In this context, suitable models are developed and applied to a 1 MW power plant where a SCADA, Supervisory Control And Data Acquisition, has been installed and operational data are available on a Web page. In order to evaluate the performance of the PV system, firstly the daily corrected Performance ratio has been evaluated. Then, different approaches to estimate the AC and the DC power of the PV plant have been developed. Basing on the difference between the measured and the estimated power, a statistical approach is proposed; it allows to define suitable thresholds on the AC and DC power in order to individuate a fault when occurs. The experimental results show the effectiveness of the proposed approach
Nonclinical assessment of the potential for herb-drug interactions between herbal extracts present in weight loss supplements and lamotrigine
Plants have been and still continue to be one of the most important sources of active ingredients. Actually, plants are still the backbone of modern pharmacopoeias and remain as a source of new drug candidates. The use of medicinal plants or plant-based medicinal products is also increasing in many developed countries as an alternative and complementary form for the treatment of diseases. Thus, the concomitant use of plants and conventional medications is emerging as a common practice in patients with hypertension, diabetes, epilepsy, depression, and oncological diseases, as well as in people with obesity and being overweight. Recently, obesity and epilepsy have been related as comorbid conditions with a high prevalence, particularly in patients with refractory epilepsy and under polytherapy. Treatment of patients with epilepsy should, therefore, take into account that the presence of comorbid conditions may compromise the efficacy and safety of antiepileptic drugs, which constitute the main therapeutic approach in epilepsy. Lamotrigine (LTG) is a well-tolerated antiepileptic drug widely used in epilepsy; however, it has a narrow therapeutic range and a considerable interindividual variability in its pharmacokinetics. Therefore, the focus of research addressed in this thesis was the nonclinical assessment of the potential for herb-drug interactions between herbal extracts present in weight loss supplements and LTG, using the rat as whole animal model. After optimization and validation of selective, precise and accurate bioanalytical methods for the quantification of LTG in human samples (plasma and saliva) and in rat samples (plasma and brain), the conditions for proceeding with nonclinical studies were met. Therefore, then a number of nonclinical studies were performed in adult male Wistar rats with the main objective of evaluating the effects of standardized extracts of Paullinia cupana (guarana), Garcinia cambogia (malabar tamarind), Citrus aurantium (bitter orange) and Fucus vesiculosus (bladderwrack) on the kinetics of LTG. To this end, at least two independent pharmacokinetic studies were carried out to evaluate the effects of each herbal extract on the pharmacokinetics of LTG; the first study aimed to evaluate the effects after the co-administration of the extract and LTG, and the second one aimed to evaluate the effects of a 14-day pre-treatment period with the extract on the pharmacokinetics of LTG subsequently administered on the 15th day. Globally, the results of the pharmacokinetic studies involving the four herbal extracts pointed out that P. cupana extract is the one that has higher potential to interact with LTG, while G. cambogia, C. aurantium and F. vesiculosus extracts had minor or no effects on LTG pharmacokinetics. The co-administration of P. cupana extract and LTG caused, in particular, a significant decrease in the peak plasma drug concentration (Cmax) and in the extent of systemic exposure to LTG over the first 24 h (AUC0-24). Based on the findings achieved in these nonclinical studies, an important pharmacokinetic interaction between P. cupana extract and LTG was herein described for the first time, which potentially may have clinical impact in patients treated with LTG. Moreover, the repeated administration of the tested herbal extracts during a 14-day period did not have relevant effects on the body weight gain of rats, which raises doubts about their effectiveness in reducing body weight. So, in conclusion, the nonclinical assessment of herb-drug interactions is of utmost importance to anticipate the potential effects of herbal preparations in the pharmacokinetics of narrow therapeutic index drugs like LTG, constituting these data the starting point for further confirmation and investigation of the relevance of these interactions at a clinical level.As plantas tĂŞm sido, e continuarĂŁo ainda a ser, uma das fontes mais importantes de princĂpios ativos. Na realidade, as plantas constituem ainda a “espinha dorsal” das farmacopeias modernas e continuam a ser uma fonte de novos candidatos a fármacos. A utilização de plantas medicinais ou de preparações medicinais Ă base de plantas está tambĂ©m a aumentar em muitos paĂses desenvolvidos como uma forma alternativa e complementar para o tratamento de doenças. Por conseguinte, o uso concomitante de plantas e medicamentos convencionais Ă© uma prática comum em doentes com hipertensĂŁo, diabetes, epilepsia, depressĂŁo e doenças oncolĂłgicas, assim como em pessoas com obesidade e excesso de peso. Recentemente, a obesidade e a epilepsia tĂŞm sido consideradas comorbilidades com uma elevada prevalĂŞncia, particularmente em doentes com epilepsia refratária e polimedicados. O tratamento de doentes com epilepsia deve, portanto, ter em consideração que a presença de comorbilidades pode comprometer a eficácia e a segurança dos fármacos antiepilĂ©ticos, os quais constituem a principal estratĂ©gia terapĂŞutica na epilepsia. A lamotrigina (LTG) Ă© um fármaco antiepilĂ©tico bem tolerado e amplamente utilizado na epilepsia, mas que apresenta uma margem terapĂŞutica estreita e uma variabilidade interindividual considerável na sua farmacocinĂ©tica. Por isso, o foco de investigação considerado nesta tese foi a avaliação nĂŁo-clĂnica do potencial de interação entre extratos de plantas presentes em suplementos Ă base de plantas para emagrecimento e a LTG, usando o rato como modelo animal. ApĂłs a otimização e a validação de mĂ©todos bioanalĂticos seletivos, precisos e exatos para a quantificação da LTG em amostras humanas (plasma e saliva) e em amostras de rato (plasma e cĂ©rebro), as condições para prosseguir com os estudos nĂŁo-clĂnicos estavam reunidas. Portanto, de seguida, um conjunto de estudos nĂŁo-clĂnicos foi realizado em ratos Wistar machos adultos com o objetivo principal de avaliar os efeitos de extratos padronizados de Paullinia cupana (guaraná), de Garcinia cambogia (tamarindo de Malabar), de Citrus aurantium (laranja-amarga) e de Fucus vesiculosus (bodelha) na cinĂ©tica da LTG. Para tal, pelo menos dois estudos farmacocinĂ©ticos independentes foram realizados para avaliar os efeitos de cada extrato na farmacocinĂ©tica da LTG; o primeiro estudo teve como objetivo avaliar os efeitos apĂłs a coadministração do extrato e da LTG, e o segundo estudo foi realizado para avaliar os efeitos de um perĂodo de prĂ©-tratamento de 14 dias com cada extrato na farmacocinĂ©tica da LTG administrada subsequentemente ao 15Âş dia. Globalmente, os resultados dos estudos farmacocinĂ©ticos envolvendo os quatro extratos de plantas revelaram que o extrato de P. cupana Ă© aquele que tem maior potencial para interagir com a LTG, enquanto que os extratos de G. cambogia, C. aurantium e F. vesiculosus tiveram poucos ou nenhuns efeitos na farmacocinĂ©tica da LTG. A coadministração do extrato de P. cupana e LTG causou, em particular, um decrĂ©scimo significativo da concentração plasmática máxima (Cmax) e da extensĂŁo de exposição sistĂ©mica Ă LTG nas primeiras 24 h (AUC0-24). Com base nos resultados obtidos nestes estudos nĂŁo-clĂnicos, uma interação farmacocinĂ©tica importante entre o extrato de P. cupana e a LTG foi aqui descrita pela primeira vez, a qual potencialmente pode ter impacto clĂnico em doentes tratados com a LTG. AlĂ©m disso, a administração repetida dos extratos testados durante um perĂodo de 14 dias nĂŁo teve efeitos relevantes sobre o ganho de peso corporal dos ratos, o que levanta dĂşvidas sobre a eficácia deles na redução do peso corporal. Assim, em conclusĂŁo, a avaliação nĂŁo-clĂnica de interações planta-fármaco Ă© de extrema importância para antecipar os efeitos potenciais de preparações Ă base de plantas na farmacocinĂ©tica de fármacos de Ăndice terapĂŞutico estreito como a LTG, constituindo esses dados o ponto de partida para confirmação posterior e investigação da relevância dessas interações a nĂvel clĂnico.UID/Multi/00709/201
Immunohistochemical detection of early myocardial infarction: a systematic review
The postmortem diagnosis of early myocardial infarction is a challenge for forensic pathologists because the routine histology is neither specific. Many authors have suggested the use of the immunohistochemistry to fill the gaps in the histological diagnosis of early myocardial infarction. This review aims to analyse advances of immunohistochemical detection of early cardiac damage due to ischaemia. To this purpose, we reviewed experimental studies that investigated immunohistochemical markers and their estimated timing of expression. The review was performed according to specific inclusion and exclusion criteria, and a total of 23 studies assessing the immunohistochemical markers for the diagnosis and timing of early myocardial infarction were identified. The literature review highlights that the analysed markers are complement components, others being inflammatory mediators, cardiac cell proteins, plasma proteins, stress or hypoxia-induced factors and proteins associated with heart failure. All studies demonstrate the effectiveness of the tested markers in the early detection of myocardial infarction in both animal and human samples
Virtual and Augmented Reality: New Frontiers for Clinical Psychology
In the last decades, the applied approach for the use of virtual reality (VR) and augmented reality (AR) on clinical and health psychology has grown exponentially. These technologies have been used to treat several mental disorders, for example, phobias, stress-related disorders, depression, eating disorders, and chronic pain. The importance of VR/AR for the mental health field comes from three main concepts: (1) VR/AR as an imaginal technology, people can feel “as if they are” in a reality that does not exist in external world; (2) VR/AR as an embodied technology, the experience to feel user’s body inside the virtual environment; and (3) VR/AR as connectivity technology, the “end of geography’. In this chapter, we explore the opportunities provided by VR/AR as technologies to improve people’s quality of life and to discuss new frontiers for their application in mental health and psychological well-being promotion
- …